Introduction: In the present study, we prospectively investigated the impact of endoscopic transnasal trans-sphenoidal surgery (ETTS) on sexual function in male and female patients with pituitary adenoma. Methods: The study included a total of 40 consecutive patients (male, n = 28 and female, n = 12) aged 22–65 years, who underwent ETTS for pituitary adenoma in our center between March 2019 and August 2019. Twenty-seven (67.5%) and 13 (32.5%) patients had functioning and nonfunctioning pituitary adenomas, respectively. Routine preoperative hormone levels were obtained in every patient. The tests were repeated at the postoperative third month. Preoperatively and at the postoperative third month, the 5-item version of the International Index of Erectile Function and the Female Sexual Function Index (FSFI) was used in male and female patients, respectively. Results: Before surgery, 24 (85.7%) men had erectile dysfunction (ED), and 10 (83%) women had female sexual dysfunction. After surgery, all the patients’ abnormal hormone parameters improved. All the male patients’ ED degrees were positively affected by surgery. In women, the FSFI was significantly better than in the preoperative period. Discussion/Conclusion: Our results showed that both males and females with pituitary adenomas benefitted from minimally invasive pituitary surgery in terms of a high-remission rate and improvement in sexual dysfunction.

1.
Lake
MG
,
Krook
LS
,
Cruz
SV
.
Pituitary adenomas: an overview
.
Am Fam Physician
.
2013 Sep
;
88
(
5
):
319
27
.
2.
Varlamov
EV
,
McCartney
S
,
Fleseriu
M
.
Functioning pituitary adenomas: current treatment options and emerging medical therapies
.
Eur Endocrinol
.
2019 Apr
;
15
(
1
):
30
40
. .
3.
Fernandez
A
,
Karavitaki
N
,
Wass
JAH
.
Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)
.
Clin Endocrinol
.
2010 Mar
;
72
(
3
):
377
82
.
4.
Nieman
LK
,
Biller
BMK
,
Findling
JW
,
Newell-Price
J
,
Savage
MO
,
Stewart
PM
,
The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline
.
J Clin Endocrinol Metab
.
2008 May
;
93
(
5
):
1526
40
.
5.
Apuzzo
ML
,
Heifetz
MD
,
Weiss
MH
,
Kurze
T
.
Neurosurgical endoscopy using the side-viewing telescope
.
J Neurosurg
.
1977 Mar
;
46
(
3
):
398
400
. .
6.
Yadav
Y
,
Sachdev
S
,
Parihar
V
,
Namdev
H
,
Bhatele
P
.
Endoscopic endonasal trans-sphenoid surgery of pituitary adenoma
.
J Neurosci Rural Pract
.
2012 Sep
;
3
(
3
):
328
37
. .
7.
Rosen
RC
,
Riley
A
,
Wagner
G
,
Osterloh
IH
,
Kirkpatrick
J
,
Mishra
A
.
The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction
.
Urology
.
1997 Jun
;
49
(
6
):
822
30
. .
8.
Rosen
R
,
Brown
C
,
Heiman
J
,
Leiblum
S
,
Meston
C
,
Shabsigh
R
,
The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function
.
J Sex Marital Ther
.
2000
;
26
(
2
):
191
208
. .
9.
Wilson
CB
.
Neurosurgical management of large and invasive pituitary tumors
. In:
Tindall
GT
,
Collins
WF
, editors.
Clinical management of pituitary disorders
. 1st ed.
New York, NY
:
Raven Press
;
1979
. p.
335
42
.
10.
Ezzat
S
,
Asa
SL
,
Couldwell
WT
,
Barr
CE
,
Dodge
WE
,
Vance
ML
,
The prevalence of pituitary adenomas: a systematic review
.
Cancer
.
2004 Aug
;
101
(
3
):
613
9
. .
11.
Jasim
S
,
Alahdab
F
,
Ahmed
AT
,
Tamhane
S
,
Prokop
LJ
,
Nippoldt
TB
,
Mortality in adults with hypopituitarism: a systematic review and meta-analysis
.
Endocrine
.
2017 Apr
;
56
(
1
):
33
42
. .
12.
Swerdloff
RS
,
Wang
C
.
Influence of pituitary disease on sexual development and functioning
.
Psychother Psychosom
.
1998
;
67
(
3
):
173
80
. .
13.
Vance
ML
.
Diagnosis, management, and prognosis of pituitary tumors
. In:
Thapar
K
,
Kovacs
K
,
Scheithauer
BW
,
Lloyd
RV
, editors.
Diagnosis and management of pituitary tumors
. 1st ed.
Totowa, NJ
:
Humana Press
;
2001
. p.
165
72
.
14.
Aflorei
ED
,
Korbonits
M
.
Epidemiology and etiopathogenesis of pituitary adenomas
.
J Neurooncol
.
2014 May
;
117
(
3
):
379
94
. .
15.
Lleva
RR
,
Inzucchi
SE
.
Diagnosis and management of pituitary adenomas
.
Curr Opin Oncol
.
2011 Jan
;
23
(
1
):
53
60
. .
16.
Cote
DJ
,
Smith
TR
,
Sandler
CN
,
Gupta
T
,
Bale
TA
,
Bi
WL
,
Functional gonadotroph adenomas: case series and report of literature
.
Neurosurgery
.
2016 Dec
;
79
(
6
):
823
31
. .
17.
Castro
MC
,
Michel
LM
,
Denaro
MM
,
Gontijo
PA
,
Sousa
AA
.
Endoscopic transnasal approach for removing pituitary tumors
.
Arq Neuropsiquiatr
.
2014 May
;
72
(
5
):
378
82
. .
18.
Gao
Y
,
Zhong
C
,
Wang
Y
,
Xu
S
,
Guo
Y
,
Dai
C
,
Endoscopic versus microscopic transsphenoidal pituitary adenoma surgery: a meta-analysis
.
World J Surg Oncol
.
2014 Apr
;
12
:
94
. .
19.
Marić
A
,
Kruljac
I
,
Čerina
V
,
Pećina
HI
,
Šulentić
P
,
Vrkljan
M
.
Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a croatian referral pituitary center experience
.
Croat Med J
.
2012 Jun
;
53
(
3
):
224
33
. .
20.
Zhou
WJ
,
Ma
SC
,
Zhao
M
,
Liu
C
,
Guan
XD
,
Bao
ZS
,
Risk factors and the prognosis of sexual dysfunction in male patients with pituitary adenomas: a multivariate analysis
.
Asian J Androl
.
2018
;
20
(
1
):
43
9
. .
21.
Rogers
A
,
Karavitaki
N
,
Wass
JA
.
Diagnosis and management of prolactinomas and non-functioning pituitary adenomas
.
BMJ
.
2014 Sep
;
349
:
g5390
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.